Adrian Cabrera, Marc Diaz, Martin Falconi, Jerome Lynch and Boris Mizrahi were selected by three judges at the FIU competition and advanced to the annual event at J&J headquarters in New Brunswick, New Jersey, taking first place.

The case required teams to select an option for J&J to follow in acquiring a new prostate cancer drug: license, buy or continue to develop internally. The winning team built the business case around licensing the drug, then buying it in year five.

“We were very confident in our strategy,” said Cabrera, who along with Falconi developed the business plan, while Diaz and Mizrahi zeroed in on the financial analysis and Lynch focused on the presentation.